MedTrace Logo

Gait Adaptation for Stroke Patients With Augmented Reality

NCT02808078 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-12-06

No results posted yet for this study

Summary

The GASPAR trial is a pragmatic, parallel-arms, single-center, non-blinded, superiority randomized control trial in neurorehabilitation. The main objective is to test whether a 4 weeks gait rehabilitation program that uses augmented reality is superior to a conventional treadmill training program of equivalent intensity. Baseline assessments precede allocation, which consists in blocking randomization (2:1 ratio) with stratification according to the disease etiology. Post-intervention assessments serve to compare the short-term efficacy of the intervention between the two groups. Three months after discharge, follow-up assessments take place to detect potential long-term effects.

Conditions

Interventions

DEVICE

Gait training with augmented reality

20 sessions (30 min. duration) over 4 weeks of gait training with augmented reality.

DEVICE

Standard training

20 sessions (30 min. duration) over 4 weeks of gait training without augmented reality.

Sponsors & Collaborators

  • Swiss Heart Foundation

    collaborator OTHER

  • Philippe Terrier

    lead NETWORK

Principal Investigators

  • Philippe Terrier, PhD · Institute for Research in Rehabilitation and Clinique romande de réadaptation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-07-31
Completion
2018-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02808078 on ClinicalTrials.gov